Peer-reviewedLicence not statedActa Pharmacologica Sinica
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
4 affiliations
- 1Nottingham Ningbo China Beacons of Excellence Research and Innovation Institute, University of Nottingham Ningbo China, Ningbo, 315100 China
- 2State Key Laboratory of Drug Research, Center for Biotherapeutics Discovery Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203 China
- 3University of Chinese Academy of Sciences, Beijing, 100049 China
- 4Key Laboratory of Glyco-drug Research of Zhejiang Province, School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024 China
Related
- Combination of antibody–drug conjugates with immunotherapy: a new paradigm in cancer treatment
- Epitope selection for combination therapy using antibody-drug conjugates and immune immune-stimulating antibody conjugates
- Advances in Somatostatin Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives.
- Enhanced cognitive protection through the combination of Amylovis-201, an anti-amyloidogenic agent with sigma-1 receptor agonist activity, and environmental enrichment in mice
- A Transparent Rule-Based Decision-Support Prototype for Diabetic Menu Planning and Meal-Combination Optimization: Development and Computational Evaluation
BibTeX
@article{liu2026recent,
title = {{Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination}},
author = {Xin-tong Liu and Feng Tang and Wei Huang},
journal = {Acta Pharmacologica Sinica},
year = {2026},
month = jul,
doi = {10.1038/s41401-026-01867-w},
url = {https://doi.org/10.1038/s41401-026-01867-w},
}
RIS
TY - JOUR
TI - Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
AU - Xin-tong Liu
AU - Feng Tang
AU - Wei Huang
PY - 2026
DA - 2026/07/17
JO - Acta Pharmacologica Sinica
DO - 10.1038/s41401-026-01867-w
UR - https://doi.org/10.1038/s41401-026-01867-w
SN - 1671-4083
SN - 1745-7254
ER -